Published in Fertil Steril on April 06, 2007
Ovarian reserve evaluation: state of the art. J Assist Reprod Genet (2008) 0.95
Biomarkers of Ovarian Reserve. Biomark Insights (2008) 0.86
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Ovarian volume correlates strongly with the number of nongrowing follicles in the human ovary. Obstet Gynecol Int (2012) 0.82
Ovarian reserve assessment for infertility investigation. ISRN Obstet Gynecol (2012) 0.82
Association between individual ovarian dimensions with ovarian reserve indices. EXCLI J (2013) 0.75
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 12.27
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril (1991) 2.50
Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update (2004) 2.47
Age and infertility. Science (1986) 2.33
Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod (2003) 2.30
Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril (1989) 2.27
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril (2002) 2.10
Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril (2000) 1.80
Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod (1997) 1.79
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril (2002) 1.78
Accuracy of ovarian reserve tests. Hum Reprod (1999) 1.54
Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod (2004) 1.51
Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol (2005) 1.51
Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH. Hum Reprod (2005) 1.47
Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod (1997) 1.44
Prognostic assessment of female fecundity. Lancet (1987) 1.42
Interobserver variation in ovarian measurements using transvaginal sonography. Gynecol Oncol (1990) 1.20
The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril (1991) 1.17
An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril (1996) 1.16
Obesity and in vitro fertilization: negative influences on outcome. J Reprod Med (2004) 1.14
Weight-related changes in reproduction function. Fertil Steril (1987) 1.14
Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril (1990) 1.10
Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod (1994) 1.10
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod (2000) 1.06
The effect of aging on fertility. Curr Opin Obstet Gynecol (1994) 1.04
Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod (1999) 1.02
Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod (2005) 1.01
The effects of smoking on ovarian function and fertility during assisted reproduction cycles. Obstet Gynecol (1996) 1.00
Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril (1997) 0.99
Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod (2003) 0.97
Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod (1999) 0.95
Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod (2003) 0.94
A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril (2002) 0.92
A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol (1993) 0.89
Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril (1994) 0.85
Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril (1984) 0.85
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders". Fertil Steril (2005) 0.83
A prospective novel method of determining ovarian size during in vitro fertilization cycles. J Assist Reprod Genet (2002) 0.82
Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online (2005) 0.81
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med (2014) 3.57
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab (2003) 2.47
Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod (2009) 2.26
Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Am J Obstet Gynecol (2008) 2.15
Implications of blood type for ovarian reserve. Hum Reprod (2011) 1.78
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med (2015) 1.65
Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause (2012) 1.65
Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation. Menopause (2009) 1.64
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril (2008) 1.64
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause (2015) 1.61
Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60
Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause (2011) 1.56
Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause (2008) 1.54
Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues (2005) 1.52
Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab (2007) 1.50
Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health (2008) 1.47
The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab (2002) 1.47
Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care (2004) 1.45
Assessing comprehension of clinical research. Contemp Clin Trials (2011) 1.44
Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation. Menopause (2015) 1.39
Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril (2009) 1.36
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab (2012) 1.24
Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab (2009) 1.22
Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol (2008) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18
Cardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Ethn Dis (2010) 1.16
The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials (2012) 1.15
Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond Engl) (2009) 1.14
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab (2006) 1.14
Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod (2010) 1.13
Overweight men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet (2010) 1.12
Relevance of vitamin D in reproduction. Hum Reprod (2012) 1.09
Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med (2005) 1.08
Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol (2010) 1.08
Age-related decline in fertility. Endocrinol Metab Clin North Am (2003) 1.08
Recruitment challenges of a multicenter randomized controlled varicocelectomy trial. Fertil Steril (2011) 1.05
Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med (2010) 1.05
Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women. J Clin Endocrinol Metab (2014) 1.05
Endometrial thickness, Caucasian ethnicity, and age predict clinical pregnancy following fresh blastocyst embryo transfer: a retrospective cohort. Reprod Biol Endocrinol (2009) 1.04
Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism (2003) 1.03
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02
Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril (2008) 1.02
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02
Predictors of chronic disease at midlife and beyond--the health risks of obesity. Maturitas (2009) 1.00
Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis (2011) 0.99
Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril (2008) 0.99
Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab (2011) 0.98
The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol (2008) 0.97
Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev (2002) 0.95
The nucleolar channel system of human endometrium is related to endoplasmic reticulum and R-rings. Mol Biol Cell (2007) 0.95
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
High prevalence of vitamin D deficiency in Pakistani mothers and their newborns. Int J Gynaecol Obstet (2011) 0.93
The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab (2003) 0.92
The Women's Health Initiative: an unforgettable decade. Menopause (2012) 0.92
Postthaw blastomere survival is predictive of the success of frozen-thawed embryo transfer cycles. Fertil Steril (2004) 0.89
Association of adolescent obesity and lifetime nulliparity--the Study of Women's Health Across the Nation (SWAN). Fertil Steril (2009) 0.89
The reproductive endocrinology of the menopausal transition. Steroids (2011) 0.89
Declining ovarian reserve adversely influences granulosa cell viability. Fertil Steril (2008) 0.88
Steroid hormone receptor profile of premenopausal endometrial polyps. Reprod Sci (2010) 0.88
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause (2008) 0.88
Cardiovascular disease and ovarian function. Curr Opin Obstet Gynecol (2011) 0.88
Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab (2014) 0.87
Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci (2008) 0.86
Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab (2012) 0.86
Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum Reprod (2009) 0.86
Onset of ovulation after menarche in girls: a longitudinal study. J Clin Endocrinol Metab (2008) 0.86
Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol (2008) 0.86
A decade after the Women's Health Initiative--the experts do agree. Fertil Steril (2012) 0.86
Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril (2008) 0.86
Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol (2012) 0.86
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Maturitas (2011) 0.85
Diminished ovarian reserve in a woman with a balanced 13;21 translocation. Fertil Steril (2008) 0.85
Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance. Am J Physiol Endocrinol Metab (2011) 0.85
Assessment of luteal function in the vervet monkey as a means to develop a model for obesity-related reproductive phenotype. Syst Biol Reprod Med (2013) 0.84
Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) (2013) 0.84
Differential granulosa cell gene expression in young women with diminished ovarian reserve. Reprod Sci (2011) 0.84
Perspective on hormone therapy 10 years after the WHI. Maturitas (2013) 0.83
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Sibling and self ovum donation for sisters with an intermediate FMR1 mutation: what's a program to do? Fertil Steril (2009) 0.82
Reproductive aging and its consequences for general health. Ann N Y Acad Sci (2010) 0.82
Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med (2004) 0.82
HIV and the menopause. Menopause Int (2008) 0.82
Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women. Clin Endocrinol (Oxf) (2014) 0.81
Comparison of SWAN and WISE menopausal status classification algorithms. J Womens Health (Larchmt) (2006) 0.81